Your browser doesn't support javascript.
loading
Advances in Mobile Health for Inflammatory Bowel Disease.
Spartz, Ellen J; DeDecker, Lauren; Le, Danny; Jalilian, Laleh; Limketkai, Berkeley N.
Afiliação
  • Spartz EJ; Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
  • DeDecker L; David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
  • Le D; Center for Inflammatory Bowel Diseases, Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
  • Jalilian L; David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
  • Limketkai BN; David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Diagnostics (Basel) ; 13(1)2022 Dec 23.
Article em En | MEDLINE | ID: mdl-36611334
Mobile health has the potential to transform the management of chronic illnesses, expanding treatment from a purely clinic-based approach to a more patient-centered delivery of care. For patients with inflammatory bowel disease (IBD), a condition characterized by a relapsing and remitting course, adoption of mobile health strategies can promote improved quality of care delivery and clinical outcomes. Benefits of mobile health applications for IBD include tracking symptoms to guide disease management, coordinating data exchange across clinical care providers, increasing communication between patients and the care team, and providing educational materials to increase patient engagement and satisfaction. In this review, we present the current offerings for telemedicine systems and mobile applications designed for patients with IBD and discuss the potential advantages and limitations of utilizing mobile health in the care of these patients.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article